Lung Cancer Workshop. Tobacco-induced Disease: Advances in Policy, Early Detection, and Management
Since 2004, the Prevent Cancer Foundation has hosted a series of annual workshops focused on the application of high resolution CT imaging data to lung cancer drug development. This unique forum brings together key leaders in lung cancer early detection and development of new therapies for management of early-stage disease:
- academic and community-based oncologists
- pulmonologists and radiologists
- experts in photonics and software development
- federal policymakers and regulators
- patient advocates
- pharmaceutical and medical imaging industries
There have been many tangible outcomes and publications resulting from the meeting series. The next goal of the workshop is to work with leading academic and the following governmental institutions to qualify volume CT in the lung as a biomarker of drug response:
- Radiological Society of North America (RSNA)
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Institute of Standards and Technology (NIST)
The Lung Cancer Workshop is co-sponsored by the Optical Society of America and the International Association for the Study of Lung Cancer.
For more details click here.